Related Experiment Videos
Growth factors and cytokines in pancreatic carcinogenesis
1Department of Visceral and Transplantation Surgery, University of Bern, Switzerland. helmut.friess@insel.ch
Abstract:
Pancreatic cancer is a deadly disease challenging basic and clinical researchers alike in characterizing its pathobiology and finding better treatment options. A number of molecular alterations including gene mutations such as k-ras, p53, and Smad4 and aberrant expression of a variety of genes have been identified in recent years. This review focuses on two families of growth factors and growth factor receptors which are representative for the molecular alterations observed in pancreatic cancer: the transforming growth factor-beta superfamily of serine-threonine kinase receptors and their ligands, which usually act as negative growth regulators, and the epidermal growth factor receptor family and their ligands, which have the potential to act as growth promoters in pancreatic cancer. In addition, we will discuss the role of the cytokines TNF-alpha, IFN-gamma, and IL-6 and its effects on pancreatic cancer cell proliferation in vitro and in vivo. Pancreatic cancer cell biology consists of complex interactions of various factors, and a better understanding of the molecular pathogenesis of this disorder might lead to better treatment strategies in the near future.
Insights
This review explores molecular alterations in pancreatic cancer, focusing on growth factors and cytokines. Understanding these factors may lead to improved pancreatic cancer treatments.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Pancreatic cancer presents significant challenges in understanding its pathobiology and developing effective treatments.
- Identified molecular alterations include mutations in genes like k-ras, p53, and Smad4, alongside aberrant gene expression.
- Growth factors and their receptors play crucial roles in cancer development.
Purpose of the Study:
- To review key molecular alterations in pancreatic cancer, specifically focusing on growth factor families and cytokines.
- To highlight the roles of the transforming growth factor-beta superfamily and epidermal growth factor receptor family in pancreatic cancer.
- To discuss the impact of cytokines such as TNF-alpha, IFN-gamma, and IL-6 on pancreatic cancer cell proliferation.
Main Methods:
- Literature review of molecular alterations in pancreatic cancer.
- Focus on growth factor signaling pathways, including TGF-beta superfamily and EGFR family.
- Examination of cytokine roles (TNF-alpha, IFN-gamma, IL-6) in cancer cell proliferation.
Main Results:
- Transforming growth factor-beta superfamily receptors and ligands typically act as negative growth regulators.
- Epidermal growth factor receptor family and their ligands can promote pancreatic cancer growth.
- Cytokines like TNF-alpha, IFN-gamma, and IL-6 influence pancreatic cancer cell proliferation both in vitro and in vivo.
Conclusions:
- Pancreatic cancer involves complex molecular interactions.
- A deeper understanding of molecular pathogenesis is essential for developing future therapeutic strategies.
- Targeting specific growth factor and cytokine pathways may offer new treatment avenues for pancreatic cancer.